Search / Trial NCT06228170

Efficacy of Stellate Ganglion Block in Traumatic Brain Injury Patients

Launched by THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY · Jan 19, 2024

Trial Information

Current as of October 04, 2024

Withdrawn

Keywords

Description

Dysphagia, or swallowing difficulty, is a common symptom in Traumatic Brain Injury Patients. The goal of this or clinical trial is to explore efficacy of stellate ganglion block on dysphagia and activities of daily living in Traumatic Brain Injury Patients. The main question it aims to answer are: Can stellate ganglion block improve the dysphagia and activities of daily living in Traumatic Brain Injury Patients. Traumatic Brain Injury Patients will be divided into the the control group and observation group evenly. All the patients were provided with routine therapy, while the patients in...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • * age ≥ 18 years, meeting the diagnosis of Traumatic Brain Injury;
  • * presence of no contraindication for Stellate Ganglion Block;
  • * with stable vital signs and no severe liver or kidney dysfunction, metabolic disorders, cardiovascular diseases, or multiple complications;
  • * informed consent form was obtained from the patient\'s family members, indicating their full understanding of the study and agreement to participate.
  • Exclusion Criteria:
  • * unable to cooperate in completing treatment and assessment due to personal reasons or other disorders;
  • * complicated with other intracranial lesions, such as stroke;
  • * with severe consciousness disorders caused by other diseases.

About Sponsor

The National Institute of Allergy and Infectious Diseases (NIAID, /ˈnaɪ.æd/) is one of the 27 institutes and centers that make up the National Institutes of Health (NIH), an agency of the United States Department of Health and Human Services (HHS). NIAID's mission is to conduct basic and applied research to better understand, treat, and prevent infectious, immunologic, and allergic diseases.

Contacts

JC

Jennifer Cobb

Immunology at National Institute of Allergy and Infectious Diseases (NIAID)

Locations

Zhengzhou, Henan, China

Mianyang, Sichuan, China

Zhengzhou, Henan, China

Zhengzhou, Henan, China

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0